Stryker Co. (NYSE:SYK) Stock Holdings Increased by Resources Investment Advisors Inc.

Resources Investment Advisors Inc. boosted its holdings in Stryker Co. (NYSE:SYK) by 17.9% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,778 shares of the medical technology company’s stock after acquiring an additional 270 shares during the period. Resources Investment Advisors Inc.’s holdings in Stryker were worth $351,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also recently bought and sold shares of the business. ERTS Wealth Advisors LLC acquired a new stake in shares of Stryker during the 4th quarter worth $25,000. Farmers National Bank acquired a new stake in shares of Stryker during the 1st quarter worth $25,000. Semmax Financial Advisors Inc. acquired a new stake in Stryker in the fourth quarter valued at about $28,000. Truehand Inc acquired a new stake in Stryker in the fourth quarter valued at about $30,000. Finally, Cable Hill Partners LLC acquired a new stake in Stryker in the first quarter valued at about $30,000. Hedge funds and other institutional investors own 73.58% of the company’s stock.

Several analysts recently weighed in on the company. Deutsche Bank raised their price objective on Stryker from $181.00 to $208.00 and gave the company a “buy” rating in a research note on Wednesday, April 24th. Zacks Investment Research downgraded Stryker from a “buy” rating to a “hold” rating in a research report on Tuesday, May 21st. ValuEngine upgraded Stryker from a “hold” rating to a “buy” rating in a research report on Friday, May 3rd. Royal Bank of Canada increased their target price on Stryker from $184.00 to $204.00 and gave the company an “outperform” rating in a research report on Monday, March 11th. Finally, Oppenheimer raised their price objective on Stryker from $183.00 to $192.00 and gave the stock an “outperform” rating in a research report on Wednesday, April 24th. Five analysts have rated the stock with a hold rating and seventeen have assigned a buy rating to the company. The company currently has an average rating of “Buy” and a consensus price target of $197.74.

In related news, VP Bijoy Sagar sold 2,000 shares of Stryker stock in a transaction that occurred on Monday, May 6th. The stock was sold at an average price of $190.43, for a total transaction of $380,860.00. Following the transaction, the vice president now owns 3,350 shares of the company’s stock, valued at $637,940.50. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Timothy J. Scannell sold 4,666 shares of the business’s stock in a transaction on Tuesday, June 18th. The stock was sold at an average price of $197.68, for a total value of $922,374.88. Following the completion of the transaction, the insider now directly owns 155,347 shares in the company, valued at approximately $30,708,994.96. The disclosure for this sale can be found here. Insiders sold 21,377 shares of company stock valued at $4,081,972 in the last three months. Insiders own 7.20% of the company’s stock.

Shares of SYK stock opened at $205.58 on Friday. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.30 and a current ratio of 2.12. Stryker Co. has a fifty-two week low of $144.75 and a fifty-two week high of $205.72. The business has a 50 day simple moving average of $191.12. The company has a market capitalization of $75.57 billion, a P/E ratio of 28.12, a P/E/G ratio of 2.47 and a beta of 0.81.

Stryker (NYSE:SYK) last announced its quarterly earnings data on Tuesday, April 23rd. The medical technology company reported $1.88 EPS for the quarter, beating the Zacks’ consensus estimate of $1.84 by $0.04. Stryker had a return on equity of 26.72% and a net margin of 25.38%. The firm had revenue of $3.52 billion during the quarter, compared to analysts’ expectations of $3.51 billion. During the same quarter last year, the firm posted $1.68 earnings per share. The company’s revenue for the quarter was up 8.5% compared to the same quarter last year. On average, research analysts predict that Stryker Co. will post 8.15 EPS for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 31st. Shareholders of record on Friday, June 28th will be paid a $0.52 dividend. The ex-dividend date is Thursday, June 27th. This represents a $2.08 dividend on an annualized basis and a yield of 1.01%. Stryker’s dividend payout ratio (DPR) is presently 28.45%.

Stryker Company Profile

Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical devices for use in various medical specialties.

Featured Story: What are the benefits of a portfolio tracker?

Institutional Ownership by Quarter for Stryker (NYSE:SYK)

Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.